Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2002
|
| gptkbp:ATCCode |
gptkb:C10AX09
|
| gptkbp:CASNumber |
gptkb:163222-33-1
|
| gptkbp:combines |
statins
|
| gptkbp:drugClass |
lipid-lowering agent
|
| gptkbp:eliminationHalfLife |
22 hours
|
| gptkbp:excretion |
urine
feces |
| gptkbp:genericName |
gptkb:ezetimibe
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zetia
|
| gptkbp:KEGGID |
D04022
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
cholesterol absorption inhibitor
|
| gptkbp:MedlinePlusID |
a603015
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionForm |
gptkb:tablet
|
| gptkbp:proteinBinding |
99%
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1201197
132497 150311 DB00973 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
fatigue headache upper respiratory tract infection |
| gptkbp:synonym |
gptkb:ezetimibe
|
| gptkbp:UNII |
A256P9T9GV
|
| gptkbp:usedFor |
gptkb:familial_hypercholesterolemia
gptkb:sitosterolemia |
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|